tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IFRX Stock Latest News

InflaRx Receives Nasdaq Deficiency Notice for Share Price
Company AnnouncementsInflaRx Receives Nasdaq Deficiency Notice for Share Price
12d ago
6K
IFRX
InflaRx receives noncompliance notification from Nasdaq
PremiumThe Fly
InflaRx receives noncompliance notification from Nasdaq
15d ago
IFRX
InflaRx Appoints KPMG as New Auditor Following Shareholder Approval
PremiumCompany Announcements
InflaRx Appoints KPMG as New Auditor Following Shareholder Approval
29d ago
6K
IFRX
InflaRx’s Strategic Shift to INF904: A Prudent Move with Promising Prospects
PremiumRatings
InflaRx’s Strategic Shift to INF904: A Prudent Move with Promising Prospects
2M ago
IFRX
InflaRx’s Strategic Shift to INF904: A Promising Focus Amidst Early-Stage Uncertainty
PremiumRatings
InflaRx’s Strategic Shift to INF904: A Promising Focus Amidst Early-Stage Uncertainty
2M ago
IFRX
InflaRx price target lowered to $3 from $6 at Oppenheimer
PremiumThe FlyInflaRx price target lowered to $3 from $6 at Oppenheimer
2M ago
IFRX
InflaRx downgraded to Outperform from Strong Buy at Raymond James
Premium
The Fly
InflaRx downgraded to Outperform from Strong Buy at Raymond James
2M ago
IFRX
InflaRx Stock (IFRX) Plummets 55% on Clinical Failure
Premium
Market News
InflaRx Stock (IFRX) Plummets 55% on Clinical Failure
2M ago
IFRX
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories
PremiumMarket News
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories
2M ago
M
KO
InflaRx Halts Vilobelimab Phase 3 Trial for Pyoderma Gangrenosum
PremiumCompany Announcements
InflaRx Halts Vilobelimab Phase 3 Trial for Pyoderma Gangrenosum
2M ago
6K
IFRX
InflaRx to discontinue vilobelimab indication following IDMC recommendation
PremiumThe Fly
InflaRx to discontinue vilobelimab indication following IDMC recommendation
2M ago
IFRX
InflaRx N.V. Reports Q1 2025 Financial Results
PremiumCompany Announcements
InflaRx N.V. Reports Q1 2025 Financial Results
3M ago
IFRX
InflaRx Reports Q1 2025 Financial Results with Reduced Losses
PremiumCompany AnnouncementsInflaRx Reports Q1 2025 Financial Results with Reduced Losses
3M ago
6K
IFRX
InflaRx reports Q1 EPS (EUR 0.13) vs (EUR 0.17) last year
Premium
The Fly
InflaRx reports Q1 EPS (EUR 0.13) vs (EUR 0.17) last year
3M ago
IFRX
Cantor starts InflaRx at Overweight ahead of upcoming Phase 3 data
Premium
The Fly
Cantor starts InflaRx at Overweight ahead of upcoming Phase 3 data
3M ago
IFRX
InflaRx initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
InflaRx initiated with an Overweight at Cantor Fitzgerald
3M ago
IFRX
InflaRx Approves Key Resolutions at Annual Shareholder Meeting
PremiumCompany Announcements
InflaRx Approves Key Resolutions at Annual Shareholder Meeting
3M ago
6K
IFRX
InflaRx N.V. Announces 2025 Annual General Meeting Agenda
PremiumCompany Announcements
InflaRx N.V. Announces 2025 Annual General Meeting Agenda
4M ago
6K
IFRX
InflaRx’s Promising Drug Pipeline and Market Potential Drive Buy Rating
PremiumRatings
InflaRx’s Promising Drug Pipeline and Market Potential Drive Buy Rating
4M ago
IFRX
InflaRx price target raised to $10 from $7 at Guggenheim
PremiumThe FlyInflaRx price target raised to $10 from $7 at Guggenheim
4M ago
IFRX
Promising Prospects for InflaRx’s Gohibic: Buy Rating Supported by Positive Phase 3 Developments and Market Potential
Premium
Ratings
Promising Prospects for InflaRx’s Gohibic: Buy Rating Supported by Positive Phase 3 Developments and Market Potential
4M ago
IFRX
InflaRx N.V. Reports 2024 Results and Key Achievements
Premium
Company Announcements
InflaRx N.V. Reports 2024 Results and Key Achievements
4M ago
IFRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >